Physician profile
Yogesh Mittal
NPI 1770545253
$6,589,541.93
in general payments reported to CMS, 2019-2025
18 companies · $1.2M in 2025
The $1.2M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $897K · 2020: $659K · 2021: $665K · 2022: $787K · 2023: $1.1M · 2024: $1.2M · 2025: $1.2M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $3.1M · Consulting Fee: $331K · Travel and Lodging: $144K · Food and Beverage: $15K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $3,092,029.23 |
| Consulting Fee | $331,375.00 |
| Travel and Lodging | $143,951.11 |
| Food and Beverage | $14,538.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,543,948.27 | 2019-2025 | Mako, Triathlon, Motionsense Digital Goniometer |
| Omnilife Science, INC | $44,623.80 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $169.85 | 2023-2024 | Rosa, Mymobility Platform |
| Globus Medical, INC. | $122.55 | 2024 | Actify |
| Davol INC. | $114.16 | 2022-2024 | Arista Ah Flexitip |
| Smith+Nephew, INC. | $87.95 | 2022-2025 | Evos, Coblation |
| Orthalign INC | $74.36 | 2024-2025 | Orthalign Plus |
| Biocomposites INC | $64.50 | 2024 | |
| Pylant Medical | $54.04 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $48.65 | 2023 | Iovera |
| Brixton Biosciences, INC. | $41.78 | 2025 | Neural Ice |
| Si-Bone, INC. | $41.57 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $35.42 | 2022 | |
| Depuy Synthes Sales INC. | $31.56 | 2023 | Na, Lcp |
| Next Science LLC | $30.86 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $25.58 | 2019 | |
| Bioventus LLC | $14.65 | 2020 | |
| Horizon Therapeutics Plc | $12.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yogesh Mittal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.